Resources
Explore how healthcare organizations, researchers, and life sciences partners from our global community use TriNetX to turn real-world patient data into evidence that drives progress.
Clinical development costs now average roughly $708 million per approved therapy. The industry’s need for accessible and trustworthy insight from real‑world data has never been greater.
We spotlight Tasfia’s work at Penn State and distilling practical lessons for other researchers navigating the complexities of cohort-based RWE studies.
Discover how real-world evidence untaps the potential of perioperative systemic therapy in muscle-invasive bladder cancer (MIBC) care.
We’re pleased to recognize Taichung Veterans General Hospital (TCVGH) as our Q2 2026 Network Spotlight winner!
TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and current TriNetX partner.
Regeneron Pharmaceuticals, Inc. and TriNetX® today announced a strategic collaboration to support Regeneron’s capabilities in drug discovery and development, as well as new initiatives to deliver digital health solutions of the future for consumers, patients and providers.
We explore how clinical data integration unifies disparate systems to deliver actionable insights.
In our latest Inside the Trends vodcast episode, COO Steve Kundrot spoke with Dr. Sarju Ganatra , a cardiologist and Co-Director of the Lahey Innovation Hub. They stripped patient-centricity back to its core.
TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation.
Run time: 31mins. Patient-centricity is everywhere in clinical research. But what does it actually look like inside real healthcare systems?
We’re proud to announce Worcestershire Acute Hospitals NHS Trust as our Q1 2026 Network Spotlight winner!
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics.
Upcoming Webinar
From Data to Evidence: A Framework for RWD Study Design & Causal Inference
Thursday, July 16 | 11am ET
Generating credible evidence from real-world data (RWD) requires more than access to data — it demands intentional alignment between the research question, study design, and data source. Yet even experienced teams fall into the trap of starting with the data and working backward, a shortcut that can undermine the trustworthiness of study findings.
Join TriNetX Chief Scientific Officer Jeffrey Brown, PhD, and Miguel Hernán, MD, PhD, ScD, Director of CAUSALab at Harvard, as they walk through a practical framework for designing rigorous RWD studies for causal inference. Attendees will leave with concrete tools for sequencing their research approach, evaluating data fitness, and applying sound decision-making to their own studies.
Join a global community of innovators. Discover how to turn real-world data into groundbreaking clinical insights.
Meet TriNetX at Events
Bridge the gap between raw data and patient care. Meet the team at flagship healthcare conferences across the globe, and learn how to leverage the TriNetX ecosystem to streamline trial timelines, improve site collaboration, and publish research that changes lives.
